Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
85 participants
OBSERVATIONAL
2010-04-30
2011-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Role of Prohepcidin in Uremic Patients
NCT01735773
A Study to Identify and Characterise Patients With Chronic Kidney Disease and Proteinuria
NCT05967806
Renoprotection by Pentoxifylline and Angiotensin Receptor Blocker in Chronic Kidney Disease (CKD)
NCT01377285
Dcr3 Levels in Blood and Urine on Renal and Patient Prognosis in Patients With Acute Kidney Injury
NCT05735093
The Role of FGF23 and Asymmetric Dimethylarginine (ADMA) in Chronic Kidney Disease
NCT01317186
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hemodialysis group
Patients on chronic hemodialysis program
No interventions assigned to this group
Peritoneal dialysis group
Patients on chronic peritoneal dialysis program
No interventions assigned to this group
Pre-dialysis group
Patients with chronic kidney disease stage-4
No interventions assigned to this group
Control group
Healthy subjects
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Hemodialysis or peritoneal dialysis for more than 3 months
* Creatinin clearance less than 30 ml/min for the pre-dialysis group
Exclusion Criteria
* Active infection within the last 3 months
* Known chronic inflammatory disease
16 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Haseki Training and Research Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Haseki Training and Research Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Haseki Training and Research Hospital
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PTX-HASEKI
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.